Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Farlow

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Geriatrics|July 1, 2004
NMDA receptor antagonists. A new therapeutic approach for Alzheimer's diseaseMartin R Farlow
Alzheimer'S Research & Therapy|June 12, 2010
Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?Martin R Farlow
The Neurologist|November 1, 2003
Update on rivastigmineMartin R Farlow
Mayo Clinic Proceedings|October 14, 2006
Use of antidementia agents in vascular dementia: beyond Alzheimer diseaseMartin R Farlow
Expert Review of Neurotherapeutics|April 28, 2005
Utilizing combination therapy in the treatment of Alzheimer's diseaseMartin R Farlow
Clinical Pharmacokinetics|December 17, 2003
Clinical pharmacokinetics of galantamineMartin R Farlow
The Primary Care Companion for CNS Disorders|March 29, 2012
Transdermal patches for the treatment of neurologic conditions in elderly patients: a reviewMartin R Farlow, Monique Somogyi
Dementia and Geriatric Cognitive Disorders|March 4, 2008
A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's diseaseMartin R Farlow, Jeffrey Cummings
The American Journal of Medicine|May 1, 2007
Effective pharmacologic management of Alzheimer's diseaseMartin R Farlow, Jeffrey L Cummings
Neurologic Clinics|July 31, 2013
Immunotherapy for Alzheimer's diseaseMartin R Farlow, Jared R Brosch
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Geriatrics|July 1, 2004
NMDA receptor antagonists. A new therapeutic approach for Alzheimer's diseaseMartin R Farlow
Alzheimer'S Research & Therapy|June 12, 2010
Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?Martin R Farlow
The Neurologist|November 1, 2003
Update on rivastigmineMartin R Farlow
Mayo Clinic Proceedings|October 14, 2006
Use of antidementia agents in vascular dementia: beyond Alzheimer diseaseMartin R Farlow
Expert Review of Neurotherapeutics|April 28, 2005
Utilizing combination therapy in the treatment of Alzheimer's diseaseMartin R Farlow
Clinical Pharmacokinetics|December 17, 2003
Clinical pharmacokinetics of galantamineMartin R Farlow
The Primary Care Companion for CNS Disorders|March 29, 2012
Transdermal patches for the treatment of neurologic conditions in elderly patients: a reviewMartin R Farlow, Monique Somogyi
Dementia and Geriatric Cognitive Disorders|March 4, 2008
A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's diseaseMartin R Farlow, Jeffrey Cummings
The American Journal of Medicine|May 1, 2007
Effective pharmacologic management of Alzheimer's diseaseMartin R Farlow, Jeffrey L Cummings
Neurologic Clinics|July 31, 2013
Immunotherapy for Alzheimer's diseaseMartin R Farlow, Jared R Brosch
Pageof 19